Ibandronate Sodium (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Ibandronate Sodium drug offered from Actavis Pharma, Inc.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | ibandronate sodium |
| SUBSTANCE NAME: | IBANDRONATE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-03-20 |
| END MARKETING DATE: | 0000-00-00 |
Ibandronate Sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ibandronate Sodium from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/1) |
| START MARKETING DATE: | 2012-03-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-3770_611c339c-262f-4801-9222-ee4498304303 |
| PRODUCT NDC: | 0591-3770 |
| APPLICATION NUMBER: | ANDA079003 |
Other IBANDRONATE SODIUM Pharmaceutical Manufacturers / Labelers:
